Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Sunday, May 03, 2015 11:18:27 AM
Musclepharm got Wynnefield Capital in and Musclepharm screwed them....Brad fooled investors to believe in 2014 profitability, Nasdaq uplisting, $50 million Q4 revenue, closure of SEC investigation and independent board....and none of it happened.
As a matter of fact, Musclepharm just diluted the stock with 5 million shares at all time lows, with 1.5 million shares protecting executives' control, votes and ownership (special rights that as a rule are reserved for existing shareholders).
Revenues dropped sharply in second half of last year, so even with $75 million in Q1 revenue, Brad and the Board have lost all credibility imo.
Fact is that the stock has gone from $14 to $4, and that the top management and the board have no chance of ever earning the trust and respect of professional investors.
MSLP will remain to be a lottery ticket for daytraders to pump and dump, but never provide any guarantee of return for long term investors.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM